|
⚲
|
| Keyboard |
| Nancy Thornberry | |
|---|---|
| Firm | |
| Address | c/o Denali Therapeutics Inc 161 Oyster Point Blvd South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Denali Therapeutics Inc | 021-506551 | Director | 499.7 M of 499.7 M |
||
| Intarcia Therapeutics Inc | 021-334622 | Director | 198.5 M of 280.0 M |
||
| Intarcia Therapeutics Inc | 021-278350 | Director | 0.0 M of 0.0 M |
||
| Intarcia Therapeutics Inc | 021-270759 | Director | 524.6 M of 850.0 M |
||
| Kallyope Inc | 021-249469 | Executive Officer | 28.1 M of 44.0 M |
||
| Intarcia Therapeutics Inc | 021-215047 | Director | 200.0 M of 200.0 M |
||
| Related People Network |
|---|
| Network #451 at Intarcia Therapeutics Inc — files alongside 24 co-filers |